Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Pierre Tiberghien and Pascal Morel.
Pierre Tiberghien
Connection Strength
0.692
Pascal Morel
  1. Convalescent plasma to treat COVID-19: Following the Argentinian lead. Transfus Apher Sci. 2021 06; 60(3):103161.
    View in: PubMed
    Score: 0.237
  2. Collecting and evaluating convalescent plasma for COVID-19 treatment: why and how? Vox Sang. 2020 Aug; 115(6):488-494.
    View in: PubMed
    Score: 0.220
  3. Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths. Sci Immunol. 2021 08 19; 6(62).
    View in: PubMed
    Score: 0.060
  4. International Forum on the Collection and Use of COVID-19 Convalescent Plasma: Protocols, Challenges and Lessons Learned: Summary. Vox Sang. 2021 11; 116(10):1117-1135.
    View in: PubMed
    Score: 0.059
  5. International Forum on the Collection and Use of COVID-19 Convalescent Plasma: Responses. Vox Sang. 2021 11; 116(10):e71-e120.
    View in: PubMed
    Score: 0.059
  6. No evidence of SARS-CoV-2 transfusion transmission despite RNA detection in blood donors showing symptoms after donation. Blood. 2020 10 15; 136(16):1888-1891.
    View in: PubMed
    Score: 0.057
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.